An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction - YUMUK, PERRAN FULDEN (My University, 2022)
Keywords: breast cancer; HER2; patient satisfaction; subcutaneous; trastuzumab